Health and Fitness Health and Fitness
Tue, February 21, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
Dehaier Medical Retains The Equity Group to Provide Investor Relations Services
[ Tue, Feb 21st 2012 ] - Market Wire
Genomma Lab Internacional Announces Non-binding P .. tige Brands Holdings for $16.60 Per Share in Cash
[ Tue, Feb 21st 2012 ] - Market Wire
Paladin Announces Strategic Partnership with Lith .. erging of South African Pharmaceutical Businesses
[ Tue, Feb 21st 2012 ] - Market Wire
EnteroMedics to Participate in 4th Annual Lazard Capital Markets Medical Technology Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Theratechnologies Announces a Supply, Distributio .. ng Agreement With Actelion Pharmaceuticals Canada
[ Tue, Feb 21st 2012 ] - Market Wire
AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Cytokinetics Announces Initiation of Phase I Clin .. tions of Omecamtiv Mecarbil in Healthy Volunteers
[ Tue, Feb 21st 2012 ] - Market Wire
Horizon Pharma to Present at the Cowen and Company Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Response Genetics Regains NASDAQ Compliance
[ Tue, Feb 21st 2012 ] - Market Wire
Repligen Announces FDA Grant of Priority Review for SecreFloa" NDA
[ Tue, Feb 21st 2012 ] - Market Wire
China Cord Blood Corporation to Report Third Quar .. irst Nine Months of Fiscal 2012 Financial Results
[ Tue, Feb 21st 2012 ] - Market Wire
Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
[ Tue, Feb 21st 2012 ] - Market Wire
PDL BioPharma to Present at Upcoming Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Oral Treprostinil New Drug Application Accepted by FDA for Review
[ Tue, Feb 21st 2012 ] - Market Wire
Oncolytics Biotech Inc. Enters into Sponsorship A .. for Randomized Phase II Study in Prostate Cancer
[ Tue, Feb 21st 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the 2012 Citi Global Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Questcor Recognized by Child Neurology Foundation .. tstanding Corporate Responsibility and Leadership
[ Tue, Feb 21st 2012 ] - Market Wire
Capital Senior Living Corporation to Present at R .. al Healthcare Conference on Wednesday, February 2
[ Tue, Feb 21st 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Positive Phas .. ults of TH-302 in Patients With Pancreatic Cancer
[ Tue, Feb 21st 2012 ] - Market Wire
GlucAffect Blood Sugar Management Formula From Reliv Earns Patent
[ Tue, Feb 21st 2012 ] - Market Wire
Simcere Pharmaceutical Group to Announce Fourth Q .. 011 Financial Results on Wednesday, March 7, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
Inovio's Scientific Advisory Board Chairman Elect .. erican Association for the Advancement of Science
Mon, February 20, 2012
[ Mon, Feb 20th 2012 ] - Market Wire
Sirona Dental Systems Validate and Approve Objet .. l Production to Their Worldwide Resellers and Den
[ Mon, Feb 20th 2012 ] - Market Wire
Galapagos announces GSK decision to exercise opti .. r investigational medicines GLPG0778 and GLPG0555
[ Mon, Feb 20th 2012 ] - Market Wire
Immunotec Announces Proposed Share Consolidation
[ Mon, Feb 20th 2012 ] - Market Wire
Immunotec Provides Corporate Update and Year End Financial Results
[ Mon, Feb 20th 2012 ] - Market Wire
Kristi Ann Matus to Head Aetnaas Government Services Organization
[ Mon, Feb 20th 2012 ] - Market Wire
Cubist Pharmaceuticals to Present at February/March Investor Conferences
[ Mon, Feb 20th 2012 ] - Market Wire
Dako Enters Into an Additional Collaboration With .. ion Diagnostic Test (pharmDx(TM)) for an Investig
[ Mon, Feb 20th 2012 ] - Market Wire
Baxter to Present at the Cowen and Company 32nd Annual Healthcare Conference

Baxter to Present at the Cowen and Company 32nd Annual Healthcare Conference


Published on 2012-02-20 07:26:00 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Cowen and Company 32nd Annual Healthcare Conference on Monday, March 5, 2012, at 1:30 p.m. ET.

The live webcast of Baxteras presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through April 4, 2012.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources